News

Featured Article

BBI’s SEM Scanner receives FDA De Novo Marketing Authorization for First-of-its-Kind Device for Objectively Assessing Patients at Risk of Pressure Ulcers

January 3rd, 2019|

BBI’s SEM Scanner receives FDA De Novo Marketing Authorization for First-of-its-Kind Device for Objectively Assessing Patients at Risk of Pressure Ulcers LOS ANGELES and MANCHESTER, U.K., 3rd January 2019 -- Bruin Biometrics, LLC (“BBI”) has [...]

Other News

Load More Posts